Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression

By Chi K.N.   Wallis A.E.   Lee C.H.   de Menezes D.L.   Sartor J.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 3, 2000-10 ,pp. : 199-212

Springer Publishing Company

Access to resources Recommend Favorite

Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR

By Rubenstein Marvin  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1212-1218

Humana Press, Inc

Access to resources Recommend Favorite

bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma

By Fontanini G.   Boldrini L.   Vignati S.   Chine S.   Basolo F.   Silvestri V.   Lucchi M.   Mussi A.   Angeletti C.A.   Bevilacqua G.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 718-723

Elsevier

Access to resources Recommend Favorite

Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 189-196

Humana Press, Inc

Access to resources Recommend Favorite

Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

By Rubenstein Marvin   Tsui Paulus   Guinan Patrick  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 372-378

Humana Press, Inc

Access to resources Recommend Favorite